O. V. Bielozorova

O. V. Bielozorova

Auto-generated profile, based on publicly available information

O. V. Bielozorova

Українська військово-медична академія

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
MPM. F. Poltorak
M. F. Poltorak
MOM. V. Orda
M. V. Orda
NKN. D. Kozak
N. D. Kozak
LLL. A. Levitska
L. A. Levitska
OBO. V. Bielozorova
O. V. Bielozorova
Вступ. Останніми роками в Україні питання дистанційного навчання перебуває у процесі постійного наукового обговорення і є новою формою навчання, включаючи військову національну освіту в Україні. Метою статті є аналіз факторів, що суттєво впливають на ефективність системи дистанційного навчання Збройних Сил України, а також розуміння світових тенденцій розвитку систем дистанційного навчання як елементу електронного навчання. Матеріали та методи. Аналіз, порівняння та систематизація наукових джерел. Результати. Проведений аналіз питань, що стосуються світових тенденцій розвитку систем дистанційного навчання як елементу електронного навчання. Розглянуто фактори, що суттєво впливають на ефективність системи дистанційного навчання Збройних Сил України. Розкрито сутність дистанційного навчання у вищих військових навчальних закладах (ВВНЗ) та військових навчальних підрозділах закладів вищої освіти (ВНП ЗВО) як особливої форми цілеспрямованого процесу оволодіння знаннями, вміннями та навичками військовими спеціалістами. Визначено основну особливість дистанційного навчання у вищих навчальних закладах та військових навчальних підрозділах закладів вищої освіти (екстериторіальність - необов’язкове перебування слухачів (курсантів) у військовому навчальному закладі; відсутність заперечення щодо участі науково-педагогічних працівників у ході проведення освітнього процесу). Висновки. Впровадження технологій дистанційного навчання в систему підготовки Збройних Сил України покликане забезпечити появу нових можливостей для оновлення змісту викладання та методики викладання дисциплін та розповсюдження знань, розширення доступу до освітніх ресурсів. Отже, це потребує подальших досліджень щодо розвитку дистанційного навчання та його впровадження, зокрема, у національній системі військової освіти.

30 March 2021
Verified
Conference Paper
Closed access
PDF file
VTV. O. Tarasenko
V. O. Tarasenko
DDD. V. Drozdov
D. V. Drozdov
OBO. V. Bielozorova
O. V. Bielozorova
OPO. V. Plieshkova
O. V. Plieshkova
ULUkrainian Military Medical Academy Senior Lecturer
Ukrainian Military Medical Academy Senior Lecturer
KAKyiv Ukrainian Military Medical Academy
Kyiv Ukrainian Military Medical Academy
The aim of this articleis to present research focused on the scientific grounding and development of a modern Ukrainian-made medical preparation with a complex effect for local treatment of wounds, in the form of an ointment, capable of anti-bacterial, anti-inflammatory and local anesthetic effect, and which does not require frequent changes in the treatment of wounded military personnel.

11 October 2021 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
OPO. V. Plieshkova
O. V. Plieshkova
OBO. V. Bielozorova
O. V. Bielozorova
ANA. V. Nikityuk
A. V. Nikityuk
Introduction. Given the leading place of chronic respiratory diseases in the morbidity of servicemen (80-90% of the total number of infectious diseases per year), the quality of medical care and its optimization is becoming increasingly medical and social. There is a rapid development of tolerance of various pathogens to existing antibacterial drugs, allergic and other side effects when using drugs. Increasing the arsenal of medicines on the Ukrainian market does not significantly improve the situation with regard to respiratory diseases in the military. The purpose. Conduct a marketing analysis of the domestic market of medicines used to provide qualified medical care to servicemen with chronic bronchitis. Materials and methods. The materials of the study were taken from a database of drugs registered in Ukraine, presented on the official website of the State Institution "State Expert Center" of the Ministry of Health of Ukraine. System-review, bibliographic, retrospective, and marketing analyzes were used to conduct the drug study. Results. It is established that in terms of the frequency of use in the treatment of servicemen with chronic bronchitis among the total number of drugs, antibacterial agents for systemic use occupy the leading third place in the number of international non-proprietary names and first place in the world. The marketing analysis of the domestic pharmaceutical market of antibacterial drugs for the provision of qualified medical care to sick servicemen with chronic bronchitis showed priority positions in the breadth of the range of CJSC "Pharmaceutical Company" Darnytsia ", LLC" FC "Health", corporation forms. In the group of antiviral drugs in demand in the treatment of chronic bronchitis has inositol pronabex imported production, dominated by solid dosage forms of tablets. The majority of mucolytics are drugs of foreign pharmaceutical companies from 10 countries, the leaders among the producing countries are Germany and India. Conclusions. The nomenclature of medicines was used to provide qualified medical care to sick servicemen with chronic bronchitis, presented on the domestic pharmaceutical market, has been studied. The geography of suppliers of medicines of certain groups is studied. The main part of the range of medicines presented on the market are drugs of foreign pharmaceutical companies. It has been established that the dominant dosage forms in the studied groups of drugs on the modern market are tablets.

25 October 2021 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
OPO. V. Plieshkova
O. V. Plieshkova
OBO. V. Bielozorova
O. V. Bielozorova
MBM. V. Bilous
M. V. Bilous
DDD. V. Drozdov
D. V. Drozdov
ANA. V. Nikituk
A. V. Nikituk
Despite the superiority of bronchitis in the structure of respiratory diseases in the military personnel, its course develops with certain peculiarities due to the peculiarities of military service. Consequently, the optimization of the costs of providing the military personnel with medicines is becoming more and more of medical and social importance. Reasonable selection of medicines in the treatment of chronic bronchitis is the result of the choice of effective and safe drugs, considering the cost of the components for military health care. Aim. To perform a pharmacoeconomic analysis of drug supply to the military personnel with chronic bronchitis. Materials and methods. The materials of the study were a database of drugs registered in Ukraine, presented on the official website of the State Institution “State Expert Center” of the Ministry of Health of Ukraine. The study employed “cost – effectiveness” method, which allows comparing the cost of a particular treatment method and its effectiveness. Results. The scheme of the pharmacoeconomic analysis method has been offered. According to the results of the previously formed list of drugs for the treatment of military personnel with chronic bronchitis, a further analysis of the proposed range of drugs is conducted using an expert survey. By calculating the efficacy ratio within each presented pharmacotherapeutic group, a 10-item list of the most optimal drugs for the treatment of chronic bronchitis has been compiled. Conclusions. Pharmacoeconomic analysis of medical supply to the military personnel is a constructive solution in the process of identifying manufacturers as potential suppliers of medicines to cover the needs of the medical service of the Armed Forces of Ukraine. Based on the results of the pharmacoeconomic analysis of the drug supply to military personnel with chronic bronchitis, a recommended list of drugs for their treatment has been formed. However, this list can be expanded to include drugs with the highest efficacy – according to the expert assessment. In the future it may become the basis for inclusion of drugs in the clinical protocols of medical care and could be used for the development of cost standards for the relevant nosological forms, which will improve the efficiency and quality of treatment and will provide economic benefits.

26 March 2026 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
DDD. V. Dovbnia
D. V. Dovbnia
AKAndrii Kaplaushenko
Andrii Kaplaushenko
RSRoman Shcherbyna
Roman Shcherbyna
OSO. O. Solomenna
O. O. Solomenna
OBO. V. Belozerova
O. V. Belozerova
VTV. V. Trokhymchuk
V. V. Trokhymchuk
Introduction. A comprehensive study aimed at the search for promising antioxidants and antihypoxants among 1,2,4-triazole-3-thione derivatives for the pharmacological correction of pathological conditions arising as a result of combat actions. The objective was to combine modern methods of computer-based prediction of toxicity and ADME parameters with experimental evaluation of antihypoxic activity in order to determine the most effective and safe candidate compounds for further preclinical and clinical trials. Materials and Methods. The objects of the study were 11 previously synthesized derivatives of 5-(2,4-, 3,4-dimethoxyphenyl)-3H-1,2,4-triazole-3-thiones [19], for which at the in silico stage acute toxicity (LD₅₀, after oral administration to rats) was predicted using TEST 5.1.2.0 software [21], as well as indices of antioxidant activity were determined [14, 19]. For the discussed series of compounds, pharmacotechnological and pharmacokinetic characteristics (solubility, bioavailability, blood–brain barrier permeability, interaction with CYP isoenzymes) were assessed using SwissADME [22]. The experimental part included the study of antihypoxic action in the model of hypoxia with hypercapnia in a closed space on white Wistar rats [23]. Animals received the tested substances at a dose of 100 mg/kg (1/10 of the predicted LD₅₀ value); armadin was used as the reference drug [24]. Results. Analysis of predictive data on acute toxicity indices showed that all studied compounds belong to toxicity classes III–IV according to the OECD classification [21], i.e., they are moderately toxic or low-toxic; thus, no highly toxic samples were identified among them. ADME analysis revealed the most optimal profile in compounds 4–7 (Table 2), which did not inhibit the main CYP450 isoenzymes and demonstrated acceptable solubility and polarity parameters. Experimental evaluation of antihypoxic activity showed that all studied substances (1–11, Table 3) prolonged the survival of animals under the experimental model, with three of them (compounds 3, 7, 8) exceeding the effectiveness of the comparison standard, the widely used drug armadin. Compound 3 prolonged life span by 51.6% relative to control, compound 7 – by 57.9%, derivative 8 – by 55.5%. At the same time, compound 3, namely 4-((5-(3,4-dimethoxyphenyl)-3H-1,2,4-triazol-3-yl)thio)butanonitrile, combined high activity with low toxicity and balanced pharmacotechnological and pharmacokinetic properties, which makes it the most promising for further studies. Conclusions. The synthesized derivatives of 1,2,4-triazole-3-thiones exhibit pronounced antioxidant and antihypoxic activity in combination with an acceptable safety profile. The most promising was defined as 4-((5-(3,4-dimethoxyphenyl)-3H-1,2,4-triazol-3-yl)thio)butanonitrile, which demonstrated an optimal “efficacy/safety” ratio, while compounds 7 and 8, although exceeding the effectiveness of armadin, require additional toxicological and pharmacokinetic analysis. The obtained results confirm the relevance of further preclinical studies of 1,2,4-triazole-3-thione derivatives as potential agents for pharmacological correction of pathological conditions induced by combat actions.